Skip to main content
Clinical Trials/CTRI/2023/02/049438
CTRI/2023/02/049438Recruiting未知

Randomized comparison of daily versus alternate day oral iron therapy in patients with ulcerative colitis with Iron deficiency anemia.

Postgraduate Institute of Medical Education and Research0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Ulcerative colitis in remission as defined by Mayo score
  • - Iron deficiency Anemia with Hemoglobin between 8 gram/dL to 12 gram/d

Exclusion Criteria

  • - Severe anemia (Hemoglobin less than 8 gram/dL)
  • - Patients with active disease of ulcerative colitis
  • - Patients with history of blood transfusion and iron therapy within last 12 weeks
  • -Patients who deny consent or do not agree for follow up
  • -Pregnant or lactating women
  • -Age < 18 years or > 100 years
  • -Crohnâ??s disease
  • -Additional causes of anemia like celiac disease, thalassemia and other hemoglobinopathies.
  • -Comorbidities like coronary artery disease, CKD or CLD requiring immediate correction of anemia
  • - Previous intolerance to oral iron therapy

Investigators

Similar Trials